AndolinaJRNeudorfSMCoreySJ. How I treat childhood CML. Blood. 2012;119:1821-1830.
2.
RoweJMLichtmanMA. Hyperleukocytosis and leukostasis: common features of childhood chronic myelogenous leukemia. Blood. 1984;63:1230-1234.
3.
BlumWPorcuP. Therapeutic aphresis in hyperleukocytosis and hyperviscosity syndrome. Semin Thromb Hemost. 2007;33:350-354.
4.
SzczpiorkowskiZMWintersJLBandarenkoNGuidelines on the use of therapeutic aphresis in clinical practice—evidence-based approach from the Aphresis Applications Committee of the American Society of Aphresis. J Clin Apher. 2010;25:83-177.
5.
HaaseRMerkelNDiwanOElsnerKKrammCM. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience. Klin Padiatr. 2009;221:374-378.
6.
VeljkovićDKuzmanovićMMićićDŠerbić-NonkovićO. Leukapheresis in management hyperleukocytosis induced complications in two pediatric patients with chronic myelogenous leukemia. Transfus Apher Sci. 2012;46:263-267.
7.
ChangYHLuMYJouSTLinDTLinKHTienHF. Forty-seven children suffering from chronic myeloid leukemia at a center over a 25-year period. Pediatr Hematol Oncol. 2003;20:505-515.
8.
MillotFTraorePGuilhotJClinical and biological features at diagnosis in 40 children with chronic myeloid leukemia. Pediatrics. 2005;116:140-143.
9.
ChenMCYangSHYaoTKChongPNChenSH. Bilateral hip pain caused by adductor pyomyositis as the initial presentation of chronic myeloid leukemia in a 17-year-old child. Pediatr Neonatol. 2011;52:353-357.